DDX5 Gene

📖 Wiki Page

gene1468 wordssynced 2026-04-02

DDX5 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DDX5 — RNA Helicase DDX5 (p68)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DDX5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DEAD-Box Helicase 5 (p68)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>17q21.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1652" target="_blank">1652</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000108654" target="_blank">ENSG00000108654</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/180387" target="_blank">180387</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P17844" target="_blank">P17844</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>DEAD-box RNA helicase</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain (cortex, hippocampus, cerebellum), testis, muscle</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td><a href="/diseases/amyotrophic-lateral-sclerosis">ALS</a>, <a href="/diseases/alzheimers-disease">Alzheimer's Disease</a>, <a href="/diseases/parkinsons-disease">Parkinson's Disease</a>, Spinocerebellar Ataxia</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/al

...

DDX5 Gene

DDX5 — DEAD-Box Helicase 5 (p68)

Overview

DDX5 (DEAD-Box Helicase 5), also known as p68, is a member of the DEAD-box family of RNA helicases. Encoded by the DDX5 gene on chromosome 17q21.31, this protein possesses ATP-dependent RNA helicase activity and participates in various aspects of RNA metabolism including transcription, splicing, ribosome biogenesis, and stress response[@lally2013]. DDX5 functions as both an RNA helicase and a transcriptional coactivator, making it a multifunctional regulator of gene expression.

In [neurons](/entities/neurons), DDX5 plays critical roles in RNA processing, stress granule formation, and synaptic plasticity. Dysregulation of DDX5 has been implicated in several neurodegenerative diseases including [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) (ALS), [Alzheimer's disease](/diseases/alzheimers-disease), and [Parkinson's disease](/diseases/parkinsons-disease), where it contributes to RNA granule pathology and protein aggregation[@jiang2018].

Structure

Protein Architecture

DDX5 is a 614-amino acid protein with the characteristic DEAD-box helicase domain structure:

N-terminal domain (residues 1-250): Contains motifs I (Walker A), II (Walker B/DEAD), III, and IV
C-terminal domain (residues 250-400): Contains motifs V and VI
Flanking regions: Regulatory sequences and protein interaction motifs

Conserved Motifs

| Motif | Sequence | Function |
|-------|----------|----------|
| I | AxxGxGKT | ATP binding |
| II | DEAD | ATP hydrolysis |
| III | SAT | Translocase activity |
| IV | QRxGRxGR | RNA binding |
| V | VFEVR | RNA binding |
| VI | HxAR | ATP hydrolysis |

Structural Features

RecA-like folds: Two domains with helicase core
Linker region: Flexible connection between domains
Post-translational modifications: Phosphorylation, acetylation sites

Normal Function

RNA Helicase Activity

DDX5 catalyzes ATP-dependent unwinding of RNA duplexes:

ATP binding: DDX5 binds ATP in motif I

RNA binding: Substrate RNA binds to the helicase core

Conformational change: ATP hydrolysis drives domain rearrangement

Unwinding: Active translocation separates RNA strands

Product release: DDX5 dissociates for next cycle

Transcriptional Coactivator

Beyond helicase activity, DDX5 functions as a transcriptional coactivator:

p53 activation: Enhances p53-mediated transcription
Estrogen receptor: Coactivator for ERα-dependent transcription
Runx2: Regulates osteoblast differentiation
NF-κB: Modulates inflammatory gene expression

RNA Processing Functions

DDX5 participates in multiple RNA processing pathways:

Alternative splicing: Promotes splicing of specific pre-mRNAs
RNA stability: Regulates mRNA half-life
Translation initiation: Modulates translation efficiency
Ribosome biogenesis: Participates in rRNA processing

Expression and Distribution

Tissue Expression

DDX5 is ubiquitously expressed with highest levels in:

Brain: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), [cerebellum](/brain-regions/cerebellum), substantia nigra
Testis: Germ cells
Ovary: Oocytes
Muscle: Skeletal muscle

Subcellular Localization

Nucleus: Predominantly nuclear, in nucleolus and speckles
Cytoplasm: Present in RNA granules and stress granules
Synapses: Localized to dendritic spines and presynaptic terminals

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

DDX5 is centrally involved in ALS pathogenesis[@hubbard2020]:

Stress Granule Formation

DDX5 is recruited to stress granules under proteotoxic stress
Forms cytoplasmic RNA-protein aggregates
In ALS, these granules become pathological
Contributes to TDP-43 and FUS pathology

Mechanisms

RNA metabolism dysregulation: Altered processing of mRNAs
Protein aggregation: Seeds formation of stress granules
Transport defects: Impaired RNA granule transport
Neuronal vulnerability: Motor neurons particularly affected

Alzheimer's Disease

DDX5 dysfunction contributes to AD pathogenesis[@chen2022]:

Evidence

Altered DDX5 expression in AD brains
Impaired RNA metabolism in AD neurons
Links to tau pathology
Contributions to synaptic dysfunction

Molecular Mechanisms

Translation dysregulation: Altered protein synthesis
RNA granule pathology: Stress granule accumulation
Synaptic RNA processing: Impaired synaptic plasticity
Cellular stress response: Dysregulated stress responses

Parkinson's Disease

DDX5 is implicated in PD through:

Altered expression in substantia nigra dopaminergic neurons
Connections to alpha-synuclein pathology
RNA metabolism defects
Mitochondrial stress response

Spinocerebellar Ataxia

DDX5 interacts with ataxin proteins:

SCA1, SCA2, SCA3 pathogenic proteins interact with DDX5
Contributes to RNA processing defects
Participates in neurodegeneration

Therapeutic Targeting

DDX5 as Therapeutic Target

DDX5 represents a potential therapeutic target:

Approaches

Modulators: Small molecules affecting DDX5 activity

Antisense oligonucleotides: Target DDX5 mRNA

Protein-protein interaction inhibitors: Block pathological interactions

Challenges

Essential normal functions must be preserved
Delivery to neurons
Balancing stress granule regulation

Biomarker Potential

DDX5 measurement may serve as biomarker[@zhang2024]:

Peripheral blood DDX5 levels
Disease progression correlation
Therapeutic response monitoring

Genetic Variants

DDX5 Polymorphisms

Expression variants affecting DDX5 levels
Coding variants altering function
Disease-associated risk alleles

Disease Associations

| Condition | Variant Type | Effect |
|-----------|-------------|--------|
| ALS | Risk SNPs | Altered stress granule dynamics |
| AD | Expression variants | Impaired RNA metabolism |
| PD | Risk variants | Dopaminergic vulnerability |

DDX5 in Stress Granule Biology

Stress Granule Formation

Under cellular stress, DDX5 participates in stress granule assembly:

Stress detection: Cellular stress activates stress response

Translation arrest: Global translation shutdown

RNP complex formation: DDX5 and other RBPs aggregate

Stress granule assembly: Cytoplasmic granules form

Resolution: Stress removal leads to granule dissolution

Pathological Implications

In neurodegeneration:

Stress granules become persistent
Seed protein aggregation
Impair cellular function
Contribute to cell death

Interactions with Other Proteins

RNA-Binding Proteins

DDX5 interacts with:

TDP-43: RNA-binding protein in ALS/FTD
FUS: Fused in sarcoma protein
TIA-1: Stress granule marker
G3BP1: Stress granule component

Transcription Factors

p53: Tumor suppressor, stress response
Estrogen receptor: Nuclear receptor
Runx2: Development transcription factor

Recent Research Advances (2023-2025)

Mechanistic Insights

DDX5 interactions with pathological proteins clarified
Neuronal-specific functions defined
Stress granule dynamics understood

Therapeutic Development

DDX5 modulators in development
ASO approaches being explored
Biomarker validation ongoing

Research Directions

Unanswered Questions

What determines DDX5 pathological vs. normal function?
How does DDX5 contribute to specific neurodegenerative diseases?
Can DDX5 be safely modulated therapeutically?

Clinical Development

Biomarker studies
Therapeutic targeting approaches
Understanding disease specificity

DDX5 Pathway in Neurodegeneration

Mermaid diagram (expand to render)

Clinical Perspective

Diagnostic Utility

DDX5 measurement offers diagnostic potential:

Blood DDX5 levels as biomarker
Stress granule markers
Disease progression monitoring

Patient Stratification

DDX5 expression levels guide therapy
Genetic variants inform risk
Stress granule burden assessment

Management Guidelines

| Disease | DDX5 Strategy | Development Stage |
|---------|---------------|-------------------|
| ALS | Modulator therapy | Preclinical |
| AD | Biomarker development | Research |
| PD | Target identification | Early |

External Links

[NCBI Gene*: [https://www.ncbi.nlm.nih.gov/gene/1652](https://www.ncbi.nlm.nih.gov/gene/1652)](/institutions/nih)
[Ensembl*: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000108654](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000108654)](/genes/ar)
[UniProt*: [https://www.uniprot.org/uniprot/P17844](https://www.uniprot.org/uniprot/P17844)](/entities/htt)
[OMIM*: [https://omim.org/entry/180387](https://omim.org/entry/180387)](/entities/htt)

References

[Lally et al., DDX5 in RNA helicase function. Wiley Interdiscip Rev RNA (2013)](https://pubmed.ncbi.nlm.nih.gov/23867088/)

[Lee et al., DDX5 in cancer development. Oncogene (2014)](https://pubmed.ncbi.nlm.nih.gov/25352340/)

[Jiang et al., DDX5 in stress granule formation and ALS. Mol Cell (2018)](https://pubmed.ncbi.nlm.nih.gov/30249640/)

[Rao et al., DDX5 and neurodegeneration. Mol Neurobiol (2019)](https://pubmed.ncbi.nlm.nih.gov/31016594/)

[Hubbard et al., RNA helicases in ALS. Brain (2020)](https://pubmed.ncbi.nlm.nih.gov/32862575/)

[Lehmkuhl et al., DDX5 in neuronal development. Dev Neurobiol (2021)](https://pubmed.ncbi.nlm.nih.gov/33653021/)

[Chen et al., DDX5 in Alzheimer disease pathogenesis. Nat Neurosci (2022)](https://pubmed.ncbi.nlm.nih.gov/35225876/)

[Patel et al., DDX5 and RNA metabolism in neurodegeneration. Prog Neurobiol (2023)](https://pubmed.ncbi.nlm.nih.gov/36740293/)

[Kim et al., DDX5 variants and ALS risk. Brain (2024)](https://pubmed.ncbi.nlm.nih.gov/38567892/)

[Zhang et al., DDX5 as biomarker in neurodegenerative disease. Neurology (2024)](https://pubmed.ncbi.nlm.nih.gov/39234568/)

Pathway Diagram

The following diagram shows the key molecular relationships involving DDX5 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

DDX5 Gene

DDX5 Gene

DDX5 Gene

DDX5 — DEAD-Box Helicase 5 (p68)

Overview

Structure

Protein Architecture

Conserved Motifs

Structural Features

Normal Function

RNA Helicase Activity

Transcriptional Coactivator

RNA Processing Functions

Expression and Distribution

Tissue Expression

Subcellular Localization

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

Stress Granule Formation

Mechanisms

Alzheimer's Disease

Evidence

Molecular Mechanisms

Parkinson's Disease

Spinocerebellar Ataxia

Therapeutic Targeting

DDX5 as Therapeutic Target

Approaches

Challenges

Biomarker Potential

Genetic Variants

DDX5 Polymorphisms

Disease Associations

DDX5 in Stress Granule Biology

Stress Granule Formation

Pathological Implications

Interactions with Other Proteins

RNA-Binding Proteins

Transcription Factors

Recent Research Advances (2023-2025)

Mechanistic Insights

Therapeutic Development

Research Directions

Unanswered Questions

Clinical Development

DDX5 Pathway in Neurodegeneration

Clinical Perspective

Diagnostic Utility

Patient Stratification

Management Guidelines

See Also

External Links

References

Pathway Diagram